Loss-of-function mutations in the gene encoding filaggrin (FLG) are present in up to 50% of patients with moderate-to-severe AD9, 10 and have been shown to increase the risk of inhalant allergic sensitization, allergic rhinitis, asthma,11, 12 and peanut allergy.13 Here, FLG is linked to asthma.